← Eichor
Condition: Alzheimers Disease Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Alzheimers Disease

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

ENhancing Outcomes in Cognitive Impairment Through Use of Home Sleep ApNea Testing
NA · 1 location(s) · Sunnybrook Health Sciences Centre · NCT04335994
The Clinical Study of Synaptic Plasticity-based Lencanumab for the Treatment of Early Alzheimer's Disease
Phase N/A · 1 location(s) · Cuibai Wei,Clinical Professor · NCT06871839
Trial to Reduce Antimicrobial Use in Nursing Home Residents With Alzheimer's Disease and Other Dementias 2.0
NA · 1 location(s) · Hebrew SeniorLife · NCT05950607
Safety and Efficacy of EXV-802 and EXV-801 in the Treatment of Agitation in Alzheimer's Disease Dementia
Phase 2/Phase 3 · 49 location(s) · Exciva GmbH · NCT07284472
A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Agitation Associated With Alzheimer's Dementia
Phase 2 · 70 location(s) · Intra-Cellular Therapies, Inc. · NCT06651567
Blood Biomarkers for Alzheimer Disease and Neuro-injury to Estimate the Association With Cognitive/Functional Decline an
Phase N/A · 3 location(s) · Istituto Nazionale di Ricovero e Cura per Anziani · NCT07435467
Evaluation of a Neuropsychological Tool to Assess Temporal Processing Abilities in Alzheimer's Disease
Phase N/A · 1 location(s) · University Hospital, Caen · NCT07341009
TAS Test: Online Motor-cognitive Tests for Early Detection of Alzheimer's Disease
Phase N/A · 1 location(s) · University of Tasmania · NCT05194787
Glutathione, Brain Metabolism and Inflammation in Alzheimer's Disease
EARLY_Phase 1 · 1 location(s) · Baylor College of Medicine · NCT04740580
Brain Wave Informed Non-invasive Brain Stimulation: Improving Neural Networks of Working Memory in Dementia: a Proof-of-
NA · 1 location(s) · McMaster University · NCT07673770
Causal Effect of Coenzyme Q10 Nutrition and Cognitive Dysfunction in the Metabolic Storm (Hyperglycemia and Sarcopenia)
NA · 1 location(s) · Chung Shan Medical University · NCT06040905
A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)
Phase 2 · 79 location(s) · Merck Sharp & Dohme LLC · NCT07033494
Infrared Light for Memory Loss in Mild Cognitive Impairment (MCI)
NA · 1 location(s) · Unity Health Toronto · NCT06618807
Alzheimer's Disease Treatment With Combination of 40Hz Light and Cognitive Therapy
Phase N/A · 1 location(s) · Alzheimer's Light LLC · NCT03657745
OCT Angiography and NRAI in Dementia
Phase N/A · 1 location(s) · Oregon Health and Science University · NCT03761381
A Study of Psychedelics in Healthy Older Adults With Low Well-being
Phase 1 · 1 location(s) · Jennifer Mitchell · NCT07386730
Tennessee Alzheimer's Project
Phase N/A · 1 location(s) · Vanderbilt University Medical Center · NCT05372172
The Swedish BioFINDER - Memory Clinic Study
Phase N/A · 1 location(s) · Skane University Hospital · NCT06122415
Advantage of Cerebellar Transcranial Magnetic Stimulation in Alzheimer's Diseases (ACT-AD)
NA · 4 location(s) · Xijing Hospital · NCT06669182
An Open-Label Study of ML-007C-MA in Adults With Alzheimer's Disease Psychosis
Phase 2 · 3 location(s) · MapLight Therapeutics · NCT07459660
A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET
Phase 3 · 126 location(s) · Bristol-Myers Squibb · NCT06976203
Cardiovascular Risk Assessment in Young Women After Index Pregnancy With and Without Placental Complications
Phase N/A · 1 location(s) · Fundació Institut de Recerca de l'Hospital de la Santa Creu · NCT07356817
Exploring the Gut-Brain Axis in Ageing and Neurodegeneration
Phase N/A · 3 location(s) · IRCCS San Camillo, Venezia, Italy · NCT05934188
A Phase 2 Study to Assess the Safety of EI-1071 and the Effects of EI-1071 on Neuroinflammation in Alzheimer's Disease P
Phase 2 · 2 location(s) · Elixiron Immunotherapeutics Inc. · NCT06745583
Dynamic Light Scattering Ocular Measurement in the Detection of Dementia
Phase N/A · 1 location(s) · MD Stem Cells · NCT06613971
Trial of CORT108297 to Attenuate the Effects of Acute Stress in the Allocortex (CORT-X)
Phase 2 · 1 location(s) · Johns Hopkins University · NCT04601038
Dominantly Inherited Alzheimer Network (DIAN)
Phase N/A · 26 location(s) · Washington University School of Medicine · NCT00869817
[18F]FT8 PET Imaging in Immunoglobulin Light Chain Amyloidosis
Phase N/A · 2 location(s) · Tianjin Medical University · NCT07232459
A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT
Phase 3 · 129 location(s) · Karuna Therapeutics, Inc., a Bristol Myers Squibb company · NCT05511363
Novel Brain Stimulation Treatment for Neuropsychiatric Symptoms in Alzheimer's Disease
NA · 1 location(s) · Baylor College of Medicine · NCT06835283
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.